The Role of Executive Functioning on Alcohol and Illegal Substance Use Among Adolescent Offenders
In: Child & adolescent social work journal
ISSN: 1573-2797
7 Ergebnisse
Sortierung:
In: Child & adolescent social work journal
ISSN: 1573-2797
In: Journal of feminist family therapy: an international forum, Band 26, Heft 3, S. 138-162
ISSN: 1540-4099
In: Journal of black studies, Band 53, Heft 2, S. 181-203
ISSN: 1552-4566
Nearly one-fourth of all undergraduate degrees received by Black students are from historically Black colleges and universities (HBCUs). HBCUs have both historical significance and present-day relevance in the promotion of Black excellence in higher education, especially in the consideration of behavioral health. The purpose of this work is to examine the present state of research surrounding behavioral health within HBCUs. A scoping review was conducted of the EbscoHost database, yielding a total of 252 articles. A total of 39 articles met the inclusion criteria and were examined within this work. Six studies informed the prevalence of behavioral health issues on campus, while the remaining articles covered a broad range of research from psychological and physical wellbeing, sexual health, violence, identity, and ideology, and finally programs and policies. Gaps and future recommendations for research and practice are discussed.
In: Research on social work practice, Band 31, Heft 2, S. 205-211
ISSN: 1552-7581
Purpose: Substance use disorders (SUDs) are on the rise, particularly concerning opioids, and existing services are still not adequately meeting treatment needs. Most treatment dropouts occur within the first few weeks of treatment, indicating health improvement is likely not occurring. In this study, a clinical dashboard tool has shown promising utility with increasing retention in SUD treatment. Method: This pilot study was designed to measure the effects of implementing a performance-based practice clinical dashboard tool and having a process for monitoring patients' recovery in a Midwestern SUD treatment center. Results: The results demonstrated the efficacy of a clinical dashboard tool that complements therapists' monitoring and measuring of their patients' performance. Discussion: Results support a building knowledge base about the impact of real-time, evidence-based tools on the retention and support of clients seeking SUD treatment.
BACKGROUND: Facing an epidemic of opioid-related mortality, many government health departments, insurers, and treatment providers have attempted to expand patient access to buprenorphine in psychosocial substance use disorder (SUD) programs and medical settings. METHODS: With Missouri Medicaid data from 2008 to 2015, we used Cox proportional hazard models to estimate the relative hazards for treatment attrition and SUD-related emergency department (ED) visits or hospitalizations associated with buprenorphine in psychosocial SUD programs and medical settings. We also tested the association of buprenorphine with hours of psychosocial treatment during the first 30 days of psychosocial SUD treatment. The analytic sample included claims from 7,606 individuals with an OUD diagnosis. RESULTS: Compared to psychosocial treatment without buprenorphine (PSY), the addition of buprenorphine (PSY-B) was associated with a significantly reduced hazard for treatment attrition (adjusted hazard ratio: 0.67, 95% CI: 0.62–0.71). Among buprenorphine episodes, office-based (B-OBOT), outpatient hospital (B-OPH), and no documented setting (B-PHA) were associated with reduced hazards for treatment attrition when compared to the psychosocial SUD setting (B-PSY) (adjusted hazard ratios: 0.27, 95% CI: 0.24–0.31; 0.46, 95% CI:0.39–0.54; 0.70, 95% CI: 0.61–0.81). Compared to B-PSY, B-OBOT and B-PHA were associated with significantly reduced hazards for a SUD-related ED visits or hospitalization (adjusted hazard ratios: 0.59, 95% CI: 0.41–0.85; 0.53, 95% CI: 0.36–0.78). There was no significant difference between B-PSY and B-OPH or B-PSY and PSY in hazard for an SUD-related ED visit or hospitalization. CONCLUSIONS: Our findings support the conclusion that adding buprenorphine to Medicaid-covered psychosocial SUD treatment reduces patient attrition and SUD-related ED visits or hospitalizations but that buprenorphine treatment in office-based medical settings is even more effective in reducing these negative outcomes. Policy-makers should ...
BASE
In: Clinical social work journal, Band 50, Heft 3, S. 308-315
ISSN: 1573-3343
In: Alcoholism treatment quarterly: the practitioner's quarterly for individual, group, and family therapy, Band 39, Heft 4, S. 517-532
ISSN: 1544-4538